SEC Form 4 · accession 0001437749-18-002616
Proto Labs Inc · PRLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Bodor
Officer — VP/General Manager-Americas
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001443669
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 12, 2018 | A | 2,622 | $105.75 | A | 19,755 | D | |
| Common Stock | Feb 13, 2018 | M | 1,891 | $57.88 | A | 21,646 | D | |
| Common StockF4 | Feb 13, 2018 | S | 1,891 | $106.0046 | D | 19,755 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $105.75 | Feb 12, 2018 | A | 3,004 | A | — | Feb 12, 2028 | Common Stock | 3,004 | 3,004 | D |
| Employee Stock Option (right to buy)F6 | $57.88 | Feb 13, 2018 | M | 1,891 | D | — | Feb 8, 2026 | Common Stock | 1,891 | 5,673 | D |
Explanation of responses
- F1The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019.
- F2Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 555 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017 and November 15, 2017.
- F3Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017.
- F4Reflects the weighted average price of 1,891 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 13, 2018 with sale prices ranging from $106.00 to $106.03 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F5The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019.
- F6The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017.